Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples